81 related articles for article (PubMed ID: 15724064)
1. Peptide analogues of a T-cell epitope of ricin toxin A-chain prevent agonist-mediated human T-cell response.
Castelletti D; Colombatti M
Int Immunol; 2005 Apr; 17(4):365-72. PubMed ID: 15724064
[TBL] [Abstract][Full Text] [Related]
2. Altered peptide ligands of islet autoantigen Imogen 38 inhibit antigen specific T cell reactivity in human type-1 diabetes.
Geluk A; van Meijgaarden KE; Roep BO; Ottenhoff TH
J Autoimmun; 1998 Aug; 11(4):353-61. PubMed ID: 9776713
[TBL] [Abstract][Full Text] [Related]
3. Identification of ricin A-chain HLA class II-restricted epitopes by human T-cell clones.
Tommasi M; Castelletti D; Pasti M; Fracasso G; Lorenzetti I; Sartoris S; Pera C; Ferrara GB; Tridente G; Colombatti M
Clin Exp Immunol; 2001 Sep; 125(3):391-400. PubMed ID: 11531946
[TBL] [Abstract][Full Text] [Related]
4. Response of a human T cell clone to a large panel of altered peptide ligands carrying single residue substitutions in an antigenic peptide: characterization and frequencies of TCR agonism and TCR antagonism with or without partial activation.
Chen YZ; Matsushita S; Nishimura Y
J Immunol; 1996 Nov; 157(9):3783-90. PubMed ID: 8892606
[TBL] [Abstract][Full Text] [Related]
5. A dominant linear B-cell epitope of ricin A-chain is the target of a neutralizing antibody response in Hodgkin's lymphoma patients treated with an anti-CD25 immunotoxin.
Castelletti D; Fracasso G; Righetti S; Tridente G; Schnell R; Engert A; Colombatti M
Clin Exp Immunol; 2004 May; 136(2):365-72. PubMed ID: 15086403
[TBL] [Abstract][Full Text] [Related]
6. Possibilities and limitations in the rational design of modified peptides for T cell mediated immunotherapy.
de Haan EC; Moret EE; Wagenaar-Hilbers JP; Liskamp RM; Wauben MH
Mol Immunol; 2005 Feb; 42(3):365-73. PubMed ID: 15589325
[TBL] [Abstract][Full Text] [Related]
7. Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells.
Kobayashi H; Nagato T; Takahara M; Sato K; Kimura S; Aoki N; Azumi M; Tateno M; Harabuchi Y; Celis E
Cancer Res; 2008 Feb; 68(3):901-8. PubMed ID: 18245493
[TBL] [Abstract][Full Text] [Related]
8. Suboptimal recognition of a T cell epitope of the major dog allergen Can f 1 by human T cells.
Juntunen R; Liukko A; Taivainen A; Närvänen A; Durand G; Kauppinen A; Nieminen A; Rytkönen-Nissinen M; Saarelainen S; Maillère B; Virtanen T; Kinnunen T
Mol Immunol; 2009 Oct; 46(16):3320-7. PubMed ID: 19700193
[TBL] [Abstract][Full Text] [Related]
9. The inhibitory effect of altered collagen II peptide on HLA-DRB1-restricted T-cell activation.
Cheng YJ; Zhou Q; Li ZG
Scand J Immunol; 2005 Mar; 61(3):260-5. PubMed ID: 15787743
[TBL] [Abstract][Full Text] [Related]
10. Limited plasticity in T cell recognition of modified T cell receptor contact residues in MHC class II bound peptides.
de Haan EC; Wagenaar-Hilbers JP; Liskamp RM; Moret EE; Wauben MH
Mol Immunol; 2005 Feb; 42(3):355-64. PubMed ID: 15589324
[TBL] [Abstract][Full Text] [Related]
11. Altered collagen II peptides inhibited T-cell activation in rheumatoid arthritis.
Li R; Li X; Li Z
Clin Immunol; 2006; 118(2-3):317-23. PubMed ID: 16343992
[TBL] [Abstract][Full Text] [Related]
12. Variable influences of iodine on the T-cell recognition of a single thyroglobulin epitope.
Jiang HY; Li HS; Carayanniotis K; Carayanniotis G
Immunology; 2007 Jul; 121(3):370-6. PubMed ID: 17376195
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of modulation of T cell responses by N-palmitoylated peptides.
Bueno C; Lee KK; Chau LA; Lee-Chan E; Singh B; Strejan GH; Madrenas J
Eur J Immunol; 2004 Dec; 34(12):3497-507. PubMed ID: 15495162
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire.
Bioley G; Dousset C; Yeh A; Dupont B; Bhardwaj N; Mears G; Old LJ; Ayyoub M; Valmori D
Clin Cancer Res; 2009 Jul; 15(13):4467-74. PubMed ID: 19531622
[TBL] [Abstract][Full Text] [Related]
15. A modified epitope identified for generation and monitoring of PSA-specific T cells in patients on early phases of PSA-based immunotherapeutic protocols.
Lundberg K; Roos AK; Pavlenko M; Leder C; Wehrum D; Guevara-Patiño J; Andersen RS; Pisa P
Vaccine; 2009 Mar; 27(10):1557-65. PubMed ID: 19171173
[TBL] [Abstract][Full Text] [Related]
16. Human T-cell leukemia virus type-I (HTLV-I)-specific T-cell responses detected using three-divided glutathione-S-transferase (GST)-Tax fusion proteins.
Kurihara K; Shimizu Y; Takamori A; Harashima N; Noji M; Masuda T; Utsunomiya A; Okamura J; Kannagi M
J Immunol Methods; 2006 Jun; 313(1-2):61-73. PubMed ID: 16723135
[TBL] [Abstract][Full Text] [Related]
17. T-cell molecular mimicry in Chagas disease: identification and partial structural analysis of multiple cross-reactive epitopes between Trypanosoma cruzi B13 and cardiac myosin heavy chain.
Iwai LK; Juliano MA; Juliano L; Kalil J; Cunha-Neto E
J Autoimmun; 2005 Mar; 24(2):111-7. PubMed ID: 15829403
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of epitope-specific cellular immune responses by immunization with HIV-1 peptides genetically conjugated to the B-subunit of recombinant cholera toxin.
Boberg A; Gaunitz S; Bråve A; Wahren B; Carlin N
Vaccine; 2008 Sep; 26(40):5079-82. PubMed ID: 18514370
[TBL] [Abstract][Full Text] [Related]
19. The response of bovine beta-lactoglobulin-specific T-cell clones to single amino acid substitution of T-cell core epitope.
Kondo M; Kaneko H; Fukao T; Suzuki K; Sakaguchi H; Shinoda S; Kato Z; Matsui E; Teramoto T; Nakano T; Kondo N
Pediatr Allergy Immunol; 2008 Nov; 19(7):592-8. PubMed ID: 18331418
[TBL] [Abstract][Full Text] [Related]
20. Altered peptide ligands narrow the repertoire of cellular immune responses by interfering with T-cell priming.
Plebanski M; Lee EA; Hannan CM; Flanagan KL; Gilbert SC; Gravenor MB; Hill AV
Nat Med; 1999 May; 5(5):565-71. PubMed ID: 10229235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
